Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > USA. M. PD-1 MAb+Multiple Kinase I.

---

USA. M. PD-1 MAb+Multiple Kinase I.'s subsections
(*) EU CE Mark Date: 2021. 11.29
(*) JP Approval Date: 2022. 02.25
(*) USA Approval Date: 2021. 08.11
Company
Generic Names>
Patent>Assignee; Claims; No.; Etc.
PR Web-Site EU
PR Web-Site JP
PR Web-Site USA
TradeMarks>

USA. M. PD-1 MAb+Multiple Kinase I.'s products
This section has no products